{"created":"2023-06-19T07:11:09.183316+00:00","id":1717,"links":{},"metadata":{"_buckets":{"deposit":"682383a3-9359-4b36-b15e-9ab1715cb019"},"_deposit":{"created_by":14,"id":"1717","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"1717"},"status":"published"},"_oai":{"id":"oai:kurume.repo.nii.ac.jp:00001717","sets":["6:315"]},"author_link":["1889"],"control_number":"1717","item_2_alternative_title_1":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"肝内に限局した進行肝細胞癌に対する肝動注化学療法（シスプラチン）と薬物療法（ソラフェニブ）の予後の比較","subitem_alternative_title_language":"ja"}]},"item_2_date_granted_9":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2022-04-01"}]},"item_2_degree_grantor_7":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"久留米大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"37104","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_2_degree_name_6":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）"}]},"item_2_description_8":{"attribute_name":"学位授与年度","attribute_value_mlt":[{"subitem_description":"2022年度","subitem_description_type":"Other"}]},"item_2_dissertation_number_10":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"乙第3024号"}]},"item_2_relation_11":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"34771452","subitem_relation_type_select":"PMID"}}]},"item_2_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.3390/cancers13215282","subitem_relation_type_select":"DOI"}}]},"item_2_relation_14":{"attribute_name":"情報源","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"Cancers 13(21):5282, 2021"}],"subitem_relation_type":"isIdenticalTo"}]},"item_2_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"財前, 友貴","creatorNameLang":"ja"},{"creatorName":"ザイゼン, ユキ","creatorNameLang":"ja-Kana"},{"creatorName":"Zaizen, Yuki","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1889","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-03-22"}],"displaytype":"detail","filename":"37104B3024.pdf","filesize":[{"value":"1004 KB"}],"format":"application/pdf","licensetype":"license_0","mimetype":"application/pdf","url":{"label":"本文","objectType":"fulltext","url":"https://kurume.repo.nii.ac.jp/record/1717/files/37104B3024.pdf"},"version_id":"b86dbc09-9b35-4cf0-88ce-03826ae523b0"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-01-16"}],"displaytype":"detail","filename":"37104B3024youshi.pdf","filesize":[{"value":"86.3 kB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"要旨","objectType":"abstract","url":"https://kurume.repo.nii.ac.jp/record/1717/files/37104B3024youshi.pdf"},"version_id":"5e6b5bb9-6c28-4a86-a7ef-80e3a517530f"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"cisplatin","subitem_subject_scheme":"Other"},{"subitem_subject":"hepatic arterial infusion chemotherapy","subitem_subject_scheme":"Other"},{"subitem_subject":"hepatocellular carcinoma","subitem_subject_scheme":"Other"},{"subitem_subject":"multikinase inhibitor","subitem_subject_scheme":"Other"},{"subitem_subject":"propensity score-matched analysis","subitem_subject_scheme":"Other"},{"subitem_subject":"risk factors","subitem_subject_scheme":"Other"},{"subitem_subject":"sorafenib","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis","subitem_title_language":"en"}]},"item_type_id":"2","owner":"14","path":["315"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-01-16"},"publish_date":"2023-01-16","publish_status":"0","recid":"1717","relation_version_is_last":true,"title":["Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2024-03-22T01:27:52.665722+00:00"}